Patent Assignment
Reel/Frame 026426/0553
Assignment of Assignor's Interest
Recorded: 2011-06-10
Pages: 8
Assignor
GILEAD PALO ALTO, INC.
Executed: 2011-05-11
Assignee
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA, 94404
Covered Properties
(49)
Partial Fatty Acid Oxidation Inhibitors in the Treatment of Congestive Heart Failure
Partial Fatty Acid Oxidation Inhibitors in the Treatment of Congestive Heart Failure
Method of treating arrhythmias
Application:
10/406,894 →
Publication:
US 2003/0220344
Method of treating diabetes
Application:
10/443,314 →
Publication:
US 2004/0063717
Method of reversing left ventricular remodeling
Application:
11/271,168 →
Publication:
US 2006/0111361
Sustained release pharmaceutical formulations
Application:
11/326,965 →
Publication:
US 2006/0177502
Method of Treating Diabetes
Method of Treating Arrhythmias
Application:
11/932,291 →
Publication:
US 2008/0109040
Use of Ranolazine for the Treatment of Cardiovascular Diseases
Application:
12/030,468 →
Publication:
US 2009/0111826
Use of Ranolazine for the Treatment of Coronary Microvascular Diseases
Application:
12/030,659 →
Publication:
US 2008/0248112
Use of Ranolazine for the Treatment of Non-Coronary Microvascular Diseases
Application:
12/030,699 →
Publication:
US 2008/0193530
Use of Ranolazine for Elevated Brain-Type Natriuretic Peptide
Application:
12/054,334 →
Publication:
US 2008/0299195
Methods for Treating Pain
Application:
12/367,403 →
Publication:
US 2009/0203707
Use of Ranolazine for the Treatment of Cardiovascular Diseases
Application:
12/370,442 →
Publication:
US 2009/0312340
Method of Reversing Left Ventricular Remodeling
Application:
12/393,952 →
Publication:
US 2009/0176772
Method of Treating Atrial Fibrillation
Application:
12/553,841 →
Publication:
US 2010/0056536
Method of Treating Arrhythmias
Application:
12/556,417 →
Publication:
US 2010/0004255
Use of Ranolazine for the Treatment of Cardiovascular Diseases
Application:
12/579,956 →
Publication:
US 2010/0035890
Co-Administration of Ranolazine and Cardiac Glycosides
Application:
12/625,403 →
Publication:
US 2010/0130436
Method of Treating Diabetes
Ranolazine for the Treatment of Cns Disorders
Application:
12/779,753 →
Publication:
US 2010/0292217
Use of partial fatty acid oxidation inhibitors for the treatment of congestive heart failure with or without angina
Application:
60/183,560 →
Use of pFox inhibitors to treat congestive heart failure
Application:
60/219,908 →
Method of treating arrhythmias
Application:
60/370,150 →
Method of treating diabetes
Application:
60/382,781 →
Method of treating arrhythmias
Application:
60/408,292 →
Method of treating arrhythmias
Application:
60/422,589 →
Method of treating diabetes
Application:
60/459,332 →
Method of preventing airway remodeling and pulmonary inflamation using A2B adenosine receptor antagonists
Application:
60/626,154 →
Sustained release pharmaceutical formulations
Application:
60/642,168 →
Use of Ranolazine for the Treatment of Cardiovascular Diseases
Application:
60/889,734 →
Use of Ranolazine for the Treatment of Cardiovascular Diseases
Application:
60/893,121 →
Use of Ranolazine for the Treatment of Cardiovascular Diseases
Application:
60/894,903 →
Use of Ranolazine for Reducing Brain-Type Natriuretic Peptide
Application:
60/896,466 →
Use of Ranolazine for the Treatment of Coronary Microvascular Diseases
Application:
60/896,477 →
Use of Ranolazine for the Treatment of Non-Coronary Microvascular Diseases
Application:
60/896,478 →
Use of Ranolazine for Reducing Brain-Type Natriuretic Peptide
Application:
60/896,845 →
Use of Ranolazine for the Treatment of Cardiovascular Diseases
Application:
60/914,645 →
Use of Ranolazine for Elevated Brain-Type Natriuretic Peptide
Application:
60/941,210 →
Use of Ranolazine for the Treatment of Cardiovascular Diseases
Application:
60/941,219 →
Use of Ranolazine for the Treatment of Cardiovascular Diseases
Application:
60/947,613 →
Methods for Treating Pain
Application:
61/026,699 →
Methods for Treating Pain
Application:
61/057,437 →
Method of Treating Atrial Fibrillation
Application:
61/094,359 →
Method of Treating Atrial Fibrillation
Application:
61/108,776 →
Co-Administration of Ranolazine and Cardiac Glycosides
Application:
61/117,927 →
RANOLAZINE SPECIFICALLY INHIBITS THE INCREASED PERSISTENT CURRENT CARRIED BY EPILEPSY-ASSOCIATED MUTANT Nav1.1 CHANNELS
Application:
61/178,170 →
Ranolazine specifically inhibits the increased persistent current carried by epilepsy-associated mutant nav1.1 channels
Application:
61/279,395 →
Use of Ranolazine for Treating Pulmonary Arterial Hypertension
Application:
61/355,462 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 6, 2003
From: BELARDINELLI, LUIZ; ANTZELEVITCH, CHARLES; BLACKBURN, BRENT
To: CV THERAPEUTICS, INC.
Reel/Frame 014350/0129 →
Assignment of Assignor's Interest
Jan 11, 2005
From: WOLFF, ANDREW A.; JERLING, MARKUS
To: CV THERAPEUTICS, INC.
Reel/Frame 015580/0218 →
Assignment of Assignor's Interest
Mar 10, 2005
From: WOLFF, ANDREW A.; JERLING, MARKUS
To: CV THERAPEUTICS, INC.
Reel/Frame 015872/0461 →
Assignment of Assignor's Interest
Feb 6, 2006
From: BLACKBURN, BRENT; SABBAH, HANI
To: CV THERAPEUTICS, INC.
Reel/Frame 017238/0779 →
Corrected Cover Sheet to Correct the Title of the Invention, Previously Recorded at Reel/Frame 017238/0779 (Assignment of Assignor's Interest)
May 10, 2006
From: BLACKBURN, BRENT; SABBAH, HANI
To: CV THERAPEUTICS, INC.
Reel/Frame 017613/0346 →
Assignment of Assignor's Interest
May 16, 2006
From: SASTRY, SRIKONDA; NYSHADHAM, JANAKI
To: CV THERAPEUTICS, INC.
Reel/Frame 017634/0852 →
Assignment of Assignor's Interest
Dec 6, 2007
From: WOLFF, ANDREW; JERLING, MARCUS
To: CV THERAPEUTICS, INC.
Reel/Frame 020207/0957 →
Assignment of Assignor's Interest
Jan 31, 2008
From: BELARDINELLI, LUIZ; ANTZELEVITCH, CHARLES; BLACKBURN, BRENT
To: CV THERAPEUTICS, INC.
Reel/Frame 020452/0207 →
Assignment of Assignor's Interest
Apr 24, 2008
From: BLACKBURN, BRENT; BELARDINELLI, LUIZ; WOLFF, ANDREW
To: CV THERAPEUTICS, INC.
Reel/Frame 020852/0065 →
Assignment of Assignor's Interest
May 15, 2009
From: RAJAMANI, SRIDHARAN; SHRYOCK, JOHN; DIAMOND, IVAN; BELARDINELLI, LUIZ
To: CV THERAPEUTICS, INC.
Reel/Frame 022688/0939 →
Assignment of Assignor's Interest
Sep 16, 2009
From: WANG, WHEDY; KARWATOWSKA-PROKOPCZUK, EWA; BELARDINELLI, LUIZ; JERLING, MARKUS
To: GILEAD PALO ALTO, INC.
Reel/Frame 023242/0379 →
Assignment of Assignor's Interest
Oct 14, 2009
From: LANGE, LOUIS; JERLING, MARKUS; WOLFF, ANDREW
To: GILEAD PALO ALTO, INC.
Reel/Frame 023372/0677 →
Assignment of Assignor's Interest
Oct 23, 2009
From: BLACKBURN, BRENT; BELARDINELLI, LUIZ; WOLFF, ANDREW
To: GILEAD PALO ALTO, INC.
Reel/Frame 023414/0477 →
Assignment of Assignor's Interest
Oct 23, 2009
From: BLACKBURN, BRENT; JERLING, MARKUS; WOLFF, ANDREW
To: GILEAD PALO ALTO, INC.
Reel/Frame 023414/0404 →
Assignment of Assignor's Interest
Oct 23, 2009
From: ANTZELEVITCH, CHARLES; BURASHNIKOV, ALEXANDER; SHRYOCK, JOHN; RAJAMANI, SRIDHARAN
To: GILEAD PALO ALTO, INC.
Reel/Frame 023417/0899 →
Assignment of Assignor's Interest
Jan 15, 2010
From: BELARDINELLI, LUIZ; HOYER, KIRSTEN; SHRYOCK, JOHN
To: GILEAD PALO ALTO, INC.
Reel/Frame 023798/0787 →
Assignment of Assignor's Interest
Jul 15, 2010
From: BELARDINELLI, LUIZ; GEORGE, ALFRED; KAHLIG, KRISTOPHER; RAJAMANI, SRIDHARAN
To: GILEAD PALO ALTO, INC.
Reel/Frame 024693/0693 →
Merger
Jul 28, 2010
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 024756/0212 →
Merger
Aug 5, 2010
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 024795/0914 →
Merger
Aug 17, 2010
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 024838/0650 →
Merger
Mar 25, 2011
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 026025/0268 →
Merger
Mar 25, 2011
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 026025/0231 →
Merger
Apr 20, 2011
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 026159/0097 →
Assignment of Assignor's Interest
Oct 12, 2012
From: WOLFF, ANDREW A.; JERLING, MARKUS
To: CV THERAPEUTICS, INC.
Reel/Frame 029123/0672 →
Assignment of Assignor's Interest
Jan 13, 2014
From: BELARDINELLI, LUIZ; ANTZELEVITCH, CHARLES; BLACKBURN, BRENT
To: CV THERAPEUTICS, INC.
Reel/Frame 031950/0055 →